{"data":{"id":"us-mt/50-32-201","jurisdiction":"us-mt","citation":"50-32-201","heading":"General criteria to be considered.","body":"In making a determination regarding a drug, the board shall consider the following:\n(1) the actual or relative potential for abuse;\n(2) the scientific evidence of its pharmacological effect, if known;\n(3) the state of current scientific knowledge regarding the drug;\n(4) the history and current pattern of abuse;\n(5) the scope, duration, and significance of abuse;\n(6) the risk to the public health;\n(7) the potential of the drug to produce psychic or physiological dependence liability; and\n(8) whether the drug is an immediate precursor of a drug already controlled under this chapter.","path":["TITLE 50. HEALTH AND SAFETY","CHAPTER 32. CONTROLLED SUBSTANCES","Part 2. Scheduling of Dangerous Drugs"],"source_url":"https://mca.legmt.gov/bills/mca/title_0500/chapter_0320/part_0020/section_0010/0500-0320-0020-0010.html","current_through":"Montana Code Annotated 2025","vintage":"","retrieved_at":"2026-09-14T04:56:24Z","sha256":"c890e5838cf98e2925afa17e5cd23329613c4ced1c4cad78f351aa346bc63ba0","source_id":"us-mt","stale":false,"prev":"us-mt/50-32-106","next":"us-mt/50-32-202"},"notice":"GroundRules: Original legal text. Not legal advice."}